Drug Shortage Report for MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Report ID | 47356 |
Drug Identification Number | 02461412 |
Brand name | MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE |
Common or Proper name | EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | EFAVIRENZ TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE |
Strength(s) | 600MG 300MG 200MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 BT |
ATC code | J05AR |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2019-06-11 |
Actual start date | |
Estimated end date | 2019-06-21 |
Actual end date | 2019-06-18 |
Shortage status | Resolved |
Updated date | 2019-06-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v24 | 2018-11-13 | English | Compare |
v23 | 2018-11-06 | French | Compare |
v22 | 2018-11-06 | English | Compare |
v21 | 2018-10-23 | French | Compare |
v20 | 2018-10-23 | English | Compare |
v19 | 2018-10-17 | French | Compare |
v18 | 2018-10-17 | English | Compare |
v17 | 2018-09-24 | French | Compare |
v16 | 2018-09-24 | English | Compare |
v15 | 2018-09-10 | French | Compare |
v14 | 2018-09-10 | English | Compare |
v13 | 2018-08-27 | French | Compare |
v12 | 2018-08-27 | English | Compare |
v11 | 2018-08-21 | French | Compare |
v10 | 2018-08-21 | English | Compare |
v7 | 2018-06-25 | English | Compare |
v8 | 2018-06-25 | English | Compare |
v9 | 2018-06-25 | English | Compare |
v6 | 2018-06-25 | English | Compare |
v5 | 2018-06-05 | French | Compare |